These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36442231)

  • 1. Systematic review on the use of biologics in adult-onset still's disease.
    Fautrel B; Patterson J; Bowe C; Arber M; Glanville J; Mealing S; Canon-Garcia V; Fagerhed L; Rabijns H; Giacomelli R
    Semin Arthritis Rheum; 2023 Feb; 58():152139. PubMed ID: 36442231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?
    Dall'Ara F; Frassi M; Tincani A; Airò P
    Clin Rheumatol; 2016 Aug; 35(8):2117-2123. PubMed ID: 26758435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
    Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs.
    Ruscitti P; McGonagle D; Garcia VC; Rabijns H; Toennessen K; Chappell M; Edwards M; Miller P; Hansell N; Moss J; Graziadio S; Feist E
    J Rheumatol; 2024 May; 51(5):442-451. PubMed ID: 38302170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment options and safety considerations when treating adult-onset Still's disease.
    Cavalli G; Farina N; Campochiaro C; Baldissera E; Dagna L
    Expert Opin Drug Saf; 2020 Dec; 19(12):1549-1558. PubMed ID: 33078630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review).
    Junge G; Mason J; Feist E
    Semin Arthritis Rheum; 2017 Oct; 47(2):295-302. PubMed ID: 28757235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug retention rates of biological agents in adult onset Still's disease.
    Campochiaro C; Farina N; Tomelleri A; De Luca G; Baldissera E; Cavalli G; Dagna L
    Semin Arthritis Rheum; 2021 Feb; 51(1):1-6. PubMed ID: 33340821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
    Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
    Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of biological agents in adult-onset Still's disease.
    Cavalli G; Franchini S; Aiello P; Guglielmi B; Berti A; Campochiaro C; Sabbadini MG; Baldissera E; Dagna L
    Scand J Rheumatol; 2015; 44(4):309-14. PubMed ID: 25656459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-onset Still's disease: Advances in the treatment.
    Castañeda S; Blanco R; González-Gay MA
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latest advances in the use of biological DMARDs to treat Still's disease.
    Di Cola I; Ruscitti P
    Expert Opin Biol Ther; 2024; 24(1-2):63-75. PubMed ID: 38284774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for the treatment of adult-onset still's disease.
    Yoo DH
    Expert Opin Biol Ther; 2019 Nov; 19(11):1173-1190. PubMed ID: 31379214
    [No Abstract]   [Full Text] [Related]  

  • 14. Anakinra for the treatment of adult-onset Still's disease.
    Castañeda S; Atienza-Mateo B; Martín-Varillas JL; Serra López-Matencio JM; González-Gay MA
    Expert Rev Clin Immunol; 2018 Dec; 14(12):979-992. PubMed ID: 30324816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of abatacept in a refractory case of adult-onset Still's disease.
    Quartuccio L; Maset M; De Vita S
    Clin Exp Rheumatol; 2010; 28(2):265-7. PubMed ID: 20483052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.
    Sfriso P; Priori R; Valesini G; Rossi S; Montecucco CM; D'Ascanio A; Carli L; Bombardieri S; LaSelva G; Iannone F; Lapadula G; Alivernini S; Ferraccioli G; Colaci M; Ferri C; Iacono D; Valentini G; Costa L; Scarpa R; LoMonaco A; Bagnari V; Govoni M; Piazza I; Adami S; Ciccia F; Triolo G; Alessandri E; Cutolo M; Cantarini L; Galeazzi M; Ruscitti P; Giacomelli R; Caso F; Galozzi P; Punzi L
    Clin Rheumatol; 2016 Jul; 35(7):1683-9. PubMed ID: 27207567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.
    Asano T; Furuya MY; Sato S; Kobayashi H; Watanabe H; Suzuki E; Migita K
    BMC Res Notes; 2018 May; 11(1):320. PubMed ID: 29784018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.
    Cipriani P; Ruscitti P; Carubbi F; Pantano I; Liakouli V; Berardicurti O; Giacomelli R
    Clin Rheumatol; 2014 Jan; 33(1):49-55. PubMed ID: 24005839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences.
    Kraetsch HG; Antoni C; Kalden JR; Manger B
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii55-7. PubMed ID: 11890655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
    Kedor C; Listing J; Zernicke J; Weiß A; Behrens F; Blank N; Henes JC; Kekow J; Rubbert-Roth A; Schulze-Koops H; Seipelt E; Specker C; Feist E
    Ann Rheum Dis; 2020 Aug; 79(8):1090-1097. PubMed ID: 32404342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.